Pharmafile Logo

Rigel

- PMLiVE

Rigel on the slide as asthma drug falls over

Share plummet after phase II failure of R343

Boehringer Ingelheim and Lilly launch diabetes education campaign

Follows the partnership’s filing of its SGLT-2 inhibitor for European approval

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links